A 5383New Jersey
Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
Passed House
Dec 8, 2025: Referred to Senate Budget and Appropriations Committee